# A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens

> **NCT01762514** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 360 (estimated)

## Conditions studied

- Nasopharyngeal Neoplasms
- Salivary Gland Diseases
- Bone Marrow Diseases
- Mucositis

## Interventions

- **DRUG:** Amifostine every-other-day regimen
- **DRUG:** Amifostine everyday regimen

## Key facts

- **NCT ID:** NCT01762514
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2019-06
- **Final completion:** 2019-12
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2017-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01762514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01762514, "A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01762514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*